25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Merck & Co. Inc
Buy, Hold or Sell?

Let's analyze Merck & Co. Inc together

I guess you are interested in Merck & Co. Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Merck & Co. Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Merck & Co. Inc

I send you an email if I find something interesting about Merck & Co. Inc.

1. Quick Overview

1.1. Quick analysis of Merck & Co. Inc (30 sec.)










1.2. What can you expect buying and holding a share of Merck & Co. Inc? (30 sec.)

How much money do you get?

How much money do you get?
€3.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€15.78
Expected worth in 1 year
€17.57
How sure are you?
84.2%

+ What do you gain per year?

Total Gains per Share
€4.56
Return On Investment
4.5%

For what price can you sell your share?

Current Price per Share
€100.60
Expected price per share
€95.81 - €105.61
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Merck & Co. Inc (5 min.)




Live pricePrice per Share (EOD)
€100.60
Intrinsic Value Per Share
€90.17 - €106.61
Total Value Per Share
€105.95 - €122.39

2.2. Growth of Merck & Co. Inc (5 min.)




Is Merck & Co. Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$43.6b$44b-$3.3b-8.1%

How much money is Merck & Co. Inc making?

Current yearPrevious yearGrowGrow %
Making money$3.7b$848.6m$2.8b77.4%
Net Profit Margin21.3%5.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Merck & Co. Inc (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#14 / 339

Most Revenue
#17 / 339

Most Profit
#8 / 339
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Merck & Co. Inc?

Welcome investor! Merck & Co. Inc's management wants to use your money to grow the business. In return you get a share of Merck & Co. Inc.

First you should know what it really means to hold a share of Merck & Co. Inc. And how you can make/lose money.

Speculation

The Price per Share of Merck & Co. Inc is €100.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Merck & Co. Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Merck & Co. Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €15.78. Based on the TTM, the Book Value Change Per Share is €0.45 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.69 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Merck & Co. Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps2.352.3%1.481.5%0.340.3%1.031.0%0.930.9%
Usd Book Value Change Per Share1.251.2%0.490.5%-0.46-0.5%0.910.9%0.910.9%
Usd Dividend Per Share0.780.8%0.750.7%0.710.7%0.680.7%0.680.7%
Usd Total Gains Per Share2.042.0%1.241.2%0.250.3%1.581.6%1.581.6%
Usd Price Per Share131.16-119.54-108.00-91.26-89.93-
Price to Earnings Ratio13.97--1.89-12.48-8.52-7.75-
Price-to-Total Gains Ratio64.41-10.27-56.61-36.01-36.01-
Price to Book Ratio7.62-7.43-6.27-6.11-5.55-
Price-to-Total Gains Ratio64.41-10.27-56.61-36.01-36.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share109.77472
Number of shares9
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.750.68
Usd Book Value Change Per Share0.490.91
Usd Total Gains Per Share1.241.58
Gains per Quarter (9 shares)11.1914.26
Gains per Year (9 shares)44.7757.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1271835243347
25435804965104
381531257398161
41097017098130218
513688215122163275
6163106260146196332
7190123305171228389
8217141350195261446
9244159395220294503
10271176440244326560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%16.03.00.084.2%16.03.00.084.2%16.03.00.084.2%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%16.03.00.084.2%16.03.00.084.2%16.03.00.084.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%16.03.00.084.2%16.03.00.084.2%16.03.00.084.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Merck & Co. Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.1480.449+156%-0.422+137%0.830+38%0.830+38%
Book Value Per Share--15.77614.740+7%15.916-1%12.535+26%11.395+38%
Current Ratio--1.4661.339+10%1.415+4%1.298+13%1.297+13%
Debt To Asset Ratio--0.6120.623-2%0.589+4%0.640-4%0.642-5%
Debt To Equity Ratio--1.5831.657-4%1.444+10%1.825-13%1.842-14%
Dividend Per Share--0.7180.691+4%0.653+10%0.621+16%0.621+16%
Eps--2.1511.355+59%0.307+600%0.940+129%0.854+152%
Free Cash Flow Per Share--1.7521.188+47%0.978+79%0.928+89%0.928+89%
Free Cash Flow To Equity Per Share--2.1910.455+382%0.747+193%0.621+253%0.621+253%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--106.613--------
Intrinsic Value_10Y_min--90.171--------
Intrinsic Value_1Y_max--5.512--------
Intrinsic Value_1Y_min--5.411--------
Intrinsic Value_3Y_max--20.503--------
Intrinsic Value_3Y_min--19.494--------
Intrinsic Value_5Y_max--40.245--------
Intrinsic Value_5Y_min--37.015--------
Market Cap--304785066294.000277582730789.400+10%251117061448.075+21%202421547160.188+51%184019588327.443+66%
Net Profit Margin--0.3390.213+59%0.058+482%0.181+87%0.187+81%
Operating Margin----0%-0%0.087-100%0.114-100%
Operating Ratio--0.8520.999-15%1.157-26%1.067-20%1.059-20%
Pb Ratio6.377-19%7.6197.430+3%6.268+22%6.109+25%5.553+37%
Pe Ratio11.690-19%13.968-1.893+114%12.476+12%8.520+64%7.746+80%
Price Per Share100.600-19%120.200109.550+10%98.975+21%83.634+44%82.418+46%
Price To Free Cash Flow Ratio14.359-19%17.156-6.625+139%66.555-74%16.690+3%15.173+13%
Price To Total Gains Ratio53.909-19%64.41210.269+527%56.609+14%36.006+79%36.006+79%
Quick Ratio--0.4490.443+1%0.452-1%0.402+12%0.405+11%
Return On Assets--0.0530.034+53%0.007+619%0.027+94%0.028+88%
Return On Equity--0.1370.089+54%0.012+1026%0.075+83%0.078+75%
Total Gains Per Share--1.8661.140+64%0.231+708%1.452+29%1.452+29%
Usd Book Value--43651701350.40040755205748.400+7%44060986054.800-1%35987951519.520+21%35235033132.000+24%
Usd Book Value Change Per Share--1.2530.489+156%-0.461+137%0.906+38%0.906+38%
Usd Book Value Per Share--17.21516.084+7%17.368-1%13.678+26%12.434+38%
Usd Dividend Per Share--0.7830.754+4%0.713+10%0.678+16%0.678+16%
Usd Eps--2.3481.478+59%0.335+600%1.026+129%0.932+152%
Usd Free Cash Flow--4846410940.8003287028716.400+47%2707229553.600+79%2307945697.200+110%2098132452.000+131%
Usd Free Cash Flow Per Share--1.9111.297+47%1.067+79%1.013+89%1.013+89%
Usd Free Cash Flow To Equity Per Share--2.3910.496+382%0.815+193%0.678+253%0.678+253%
Usd Market Cap--332581464340.013302898275837.393+10%274018937452.139+21%220882392261.197+51%200802174782.906+66%
Usd Price Per Share109.775-19%131.162119.541+10%108.002+21%91.261+44%89.934+46%
Usd Profit--5952496000.0003747180800.000+59%848680800.000+601%2699356000.000+121%2730976000.000+118%
Usd Revenue--17581414400.00017044271200.000+3%15907240800.000+11%14933126560.000+18%14695339200.000+20%
Usd Total Gains Per Share--2.0361.244+64%0.252+708%1.584+29%1.584+29%
 EOD+4 -2MRQTTM+30 -4YOY+25 -95Y+30 -510Y+30 -5

3.3 Fundamental Score

Let's check the fundamental score of Merck & Co. Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.690
Price to Book Ratio (EOD)Between0-16.377
Net Profit Margin (MRQ)Greater than00.339
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.449
Current Ratio (MRQ)Greater than11.466
Debt to Asset Ratio (MRQ)Less than10.612
Debt to Equity Ratio (MRQ)Less than11.583
Return on Equity (MRQ)Greater than0.150.137
Return on Assets (MRQ)Greater than0.050.053
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Merck & Co. Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose100.200
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Merck & Co. Inc

  • Other
  • 0

There is no Profile data available for 6MK.BE.

Fundamental data was last updated by Penke on 2024-10-04 23:28:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Merck & Co. Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • A Net Profit Margin of 33.9% means that €0.34 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck & Co. Inc:

  • The MRQ is 33.9%. The company is making a huge profit. +2
  • The TTM is 21.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.9%TTM21.3%+12.5%
TTM21.3%YOY5.8%+15.5%
TTM21.3%5Y18.1%+3.3%
5Y18.1%10Y18.7%-0.6%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ33.9%6.2%+27.7%
TTM21.3%5.8%+15.5%
YOY5.8%5.8%+0.0%
5Y18.1%6.1%+12.0%
10Y18.7%6.2%+12.5%
4.3.1.2. Return on Assets

Shows how efficient Merck & Co. Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • 5.3% Return on Assets means that Merck & Co. Inc generated €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck & Co. Inc:

  • The MRQ is 5.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 3.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.3%TTM3.4%+1.8%
TTM3.4%YOY0.7%+2.7%
TTM3.4%5Y2.7%+0.7%
5Y2.7%10Y2.8%-0.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3%1.3%+4.0%
TTM3.4%1.1%+2.3%
YOY0.7%1.4%-0.7%
5Y2.7%1.2%+1.5%
10Y2.8%1.4%+1.4%
4.3.1.3. Return on Equity

Shows how efficient Merck & Co. Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • 13.7% Return on Equity means Merck & Co. Inc generated €0.14 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck & Co. Inc:

  • The MRQ is 13.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.7%TTM8.9%+4.8%
TTM8.9%YOY1.2%+7.7%
TTM8.9%5Y7.5%+1.4%
5Y7.5%10Y7.8%-0.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7%3.6%+10.1%
TTM8.9%3.4%+5.5%
YOY1.2%4.4%-3.2%
5Y7.5%3.8%+3.7%
10Y7.8%3.8%+4.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Merck & Co. Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Merck & Co. Inc is operating .

  • Measures how much profit Merck & Co. Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck & Co. Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.7%-8.7%
5Y8.7%10Y11.4%-2.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.4%-8.4%
TTM-5.0%-5.0%
YOY-7.7%-7.7%
5Y8.7%4.9%+3.8%
10Y11.4%6.8%+4.6%
4.3.2.2. Operating Ratio

Measures how efficient Merck & Co. Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 0.85 means that the operating costs are €0.85 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.852. The company is less efficient in keeping operating costs low.
  • The TTM is 0.999. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.852TTM0.999-0.147
TTM0.999YOY1.157-0.158
TTM0.9995Y1.067-0.068
5Y1.06710Y1.059+0.008
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8521.279-0.427
TTM0.9991.344-0.345
YOY1.1571.340-0.183
5Y1.0671.291-0.224
10Y1.0591.379-0.320
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Merck & Co. Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Merck & Co. Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.47 means the company has €1.47 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck & Co. Inc:

  • The MRQ is 1.466. The company is just able to pay all its short-term debts.
  • The TTM is 1.339. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.466TTM1.339+0.127
TTM1.339YOY1.415-0.076
TTM1.3395Y1.298+0.041
5Y1.29810Y1.297+0.001
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4661.423+0.043
TTM1.3391.466-0.127
YOY1.4151.568-0.153
5Y1.2981.555-0.257
10Y1.2971.498-0.201
4.4.3.2. Quick Ratio

Measures if Merck & Co. Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • A Quick Ratio of 0.45 means the company can pay off €0.45 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.449. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.443. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.449TTM0.443+0.005
TTM0.443YOY0.452-0.009
TTM0.4435Y0.402+0.041
5Y0.40210Y0.405-0.003
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4490.542-0.093
TTM0.4430.554-0.111
YOY0.4520.579-0.127
5Y0.4020.607-0.205
10Y0.4050.608-0.203
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Merck & Co. Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Merck & Co. Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Merck & Co. Inc to Other industry mean.
  • A Debt to Asset Ratio of 0.61 means that Merck & Co. Inc assets are financed with 61.2% credit (debt) and the remaining percentage (100% - 61.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Merck & Co. Inc:

  • The MRQ is 0.612. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.623. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.612TTM0.623-0.010
TTM0.623YOY0.589+0.034
TTM0.6235Y0.640-0.017
5Y0.64010Y0.642-0.002
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6120.527+0.085
TTM0.6230.534+0.089
YOY0.5890.545+0.044
5Y0.6400.553+0.087
10Y0.6420.563+0.079
4.5.4.2. Debt to Equity Ratio

Measures if Merck & Co. Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Merck & Co. Inc to the Other industry mean.
  • A Debt to Equity ratio of 158.3% means that company has €1.58 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck & Co. Inc:

  • The MRQ is 1.583. The company is just able to pay all its debts with equity.
  • The TTM is 1.657. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.583TTM1.657-0.074
TTM1.657YOY1.444+0.212
TTM1.6575Y1.825-0.169
5Y1.82510Y1.842-0.017
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5831.110+0.473
TTM1.6571.130+0.527
YOY1.4441.236+0.208
5Y1.8251.318+0.507
10Y1.8421.435+0.407
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Merck & Co. Inc generates.

  • Above 15 is considered overpriced but always compare Merck & Co. Inc to the Other industry mean.
  • A PE ratio of 13.97 means the investor is paying €13.97 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck & Co. Inc:

  • The EOD is 11.690. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.968. Based on the earnings, the company is underpriced. +1
  • The TTM is -1.893. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.690MRQ13.968-2.278
MRQ13.968TTM-1.893+15.861
TTM-1.893YOY12.476-14.369
TTM-1.8935Y8.520-10.413
5Y8.52010Y7.746+0.775
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD11.69014.018-2.328
MRQ13.96812.120+1.848
TTM-1.89311.675-13.568
YOY12.47611.291+1.185
5Y8.52012.102-3.582
10Y7.74612.409-4.663
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Merck & Co. Inc:

  • The EOD is 14.359. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 17.156. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -6.625. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD14.359MRQ17.156-2.797
MRQ17.156TTM-6.625+23.781
TTM-6.625YOY66.555-73.180
TTM-6.6255Y16.690-23.315
5Y16.69010Y15.173+1.517
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD14.3599.380+4.979
MRQ17.1568.337+8.819
TTM-6.6257.122-13.747
YOY66.5551.440+65.115
5Y16.6902.775+13.915
10Y15.1734.090+11.083
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Merck & Co. Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 7.62 means the investor is paying €7.62 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Merck & Co. Inc:

  • The EOD is 6.377. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.619. Based on the equity, the company is overpriced. -1
  • The TTM is 7.430. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.377MRQ7.619-1.242
MRQ7.619TTM7.430+0.189
TTM7.430YOY6.268+1.162
TTM7.4305Y6.109+1.321
5Y6.10910Y5.553+0.555
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD6.3771.596+4.781
MRQ7.6191.400+6.219
TTM7.4301.408+6.022
YOY6.2681.379+4.889
5Y6.1091.640+4.469
10Y5.5531.697+3.856
4.6.2. Total Gains per Share

2.4. Latest News of Merck & Co. Inc

Does Merck & Co. Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Merck & Co. Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2024-10-14
14:27
erck & Co. (MRK): Winrevair Approval Drives Cardiovascular GrowthRead
2024-10-14
14:00
Exelixis and Merck Sign Clinical Development Collaboration to Evaluate Investigational Zanzalintinib in Combination with KEYTRUDA® (pembrolizumab) in Head and Neck Cancer and in Combination with WELIREG® (belzutifan) in Renal Cell CarcinomaRead
2024-10-12
18:37
Is Merck & Co. Inc. (MRK) The Most Undervalued Quality Stock To Buy According To Analysts?Read
2024-10-11
16:00
Does Merck (NYSE:MRK) Have A Healthy Balance Sheet?Read
2024-10-11
15:00
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on ItRead
2024-10-11
14:38
Should You Invest in Merck & Co. (MRK)?Read
2024-10-10
16:57
Is Merck & Co Inc. (MRK) the Best Quality Stock to Buy According to Analysts?Read
2024-10-08
21:44
Merck & Co., Inc. (MRK) is One of The Best Cheap Stocks to Buy According to Billionaire Ray DalioRead
2024-10-06
21:36
Merck & Co Inc. (MRK): Analysts Are Bullish On This Quality Stock Right NowRead
2024-10-01
12:45
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon BiopharmaceuticalRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets112,630,000
Total Liabilities68,982,000
Total Stockholder Equity43,582,000
 As reported
Total Liabilities 68,982,000
Total Stockholder Equity+ 43,582,000
Total Assets = 112,630,000

Assets

Total Assets112,630,000
Total Current Assets38,205,000
Long-term Assets74,425,000
Total Current Assets
Cash And Cash Equivalents 11,304,000
Short-term Investments 50,000
Net Receivables 11,642,000
Inventory 6,469,000
Other Current Assets 8,740,000
Total Current Assets  (as reported)38,205,000
Total Current Assets  (calculated)38,205,000
+/-0
Long-term Assets
Property Plant Equipment 23,221,000
Goodwill 21,161,000
Long Term Investments 357,000
Intangible Assets 16,984,000
Long-term Assets Other 12,702,000
Long-term Assets  (as reported)74,425,000
Long-term Assets  (calculated)74,425,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities26,060,000
Long-term Liabilities42,922,000
Total Stockholder Equity43,582,000
Total Current Liabilities
Short Long Term Debt 3,071,000
Accounts payable 3,519,000
Total Current Liabilities  (as reported)26,060,000
Total Current Liabilities  (calculated)6,590,000
+/- 19,470,000
Long-term Liabilities
Long term Debt 34,717,000
Long-term Liabilities Other 7,329,000
Long-term Liabilities  (as reported)42,922,000
Long-term Liabilities  (calculated)42,046,000
+/- 876,000
Total Stockholder Equity
Retained Earnings 60,187,000
Total Stockholder Equity (as reported)43,582,000
Total Stockholder Equity (calculated)60,187,000
+/- 16,605,000
Other
Capital Stock1,788,000
Common Stock Shares Outstanding 2,535,649
Net Debt 26,484,000
Net Invested Capital 81,370,000
Net Working Capital 12,145,000
Property Plant and Equipment Gross 42,181,000



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
82,354,000
83,965,000
83,331,000
84,397,000
84,913,000
90,615,000
89,800,000
91,588,000
90,847,000
90,688,000
93,494,000
105,694,000
106,668,000
107,095,000
107,081,000
109,160,000
107,796,000
104,469,000
106,727,000
106,675,000
105,849,000
112,630,000
112,630,000105,849,000106,675,000106,727,000104,469,000107,796,000109,160,000107,081,000107,095,000106,668,000105,694,00093,494,00090,688,00090,847,00091,588,00089,800,00090,615,00084,913,00084,397,00083,331,00083,965,00082,354,000
   > Total Current Assets 
25,351,000
24,298,000
26,142,000
27,483,000
26,174,000
29,343,000
26,577,000
27,764,000
26,909,000
28,665,000
31,058,000
30,266,000
31,184,000
32,116,000
33,561,000
35,722,000
33,402,000
29,977,000
31,954,000
32,168,000
31,445,000
38,205,000
38,205,00031,445,00032,168,00031,954,00029,977,00033,402,00035,722,00033,561,00032,116,00031,184,00030,266,00031,058,00028,665,00026,909,00027,764,00026,577,00029,343,00026,174,00027,483,00026,142,00024,298,00025,351,000
       Cash And Cash Equivalents 
8,076,000
6,659,000
7,869,000
9,676,000
7,425,000
11,103,000
7,356,000
8,062,000
6,981,000
8,575,000
10,016,000
8,096,000
8,556,000
9,675,000
11,145,000
12,694,000
9,707,000
5,660,000
8,605,000
6,841,000
5,579,000
11,304,000
11,304,0005,579,0006,841,0008,605,0005,660,0009,707,00012,694,00011,145,0009,675,0008,556,0008,096,00010,016,0008,575,0006,981,0008,062,0007,356,00011,103,0007,425,0009,676,0007,869,0006,659,0008,076,000
       Short-term Investments 
722,000
446,000
149,000
774,000
7,000
0
0
0
0
0
0
0
372,000
453,000
103,000
498,000
680,000
718,000
168,000
252,000
40,000
50,000
50,00040,000252,000168,000718,000680,000498,000103,000453,000372,00000000007,000774,000149,000446,000722,000
       Net Receivables 
7,608,000
7,964,000
8,442,000
6,778,000
8,182,000
7,577,000
8,422,000
7,851,000
8,235,000
7,843,000
8,571,000
9,230,000
9,828,000
9,643,000
9,482,000
9,450,000
10,415,000
11,030,000
10,394,000
10,349,000
11,366,000
11,642,000
11,642,00011,366,00010,349,00010,394,00011,030,00010,415,0009,450,0009,482,0009,643,0009,828,0009,230,0008,571,0007,843,0008,235,0007,851,0008,422,0007,577,0008,182,0006,778,0008,442,0007,964,0007,608,000
       Inventory 
5,712,000
5,847,000
7,370,000
5,978,000
7,476,000
7,977,000
8,209,000
6,310,000
8,577,000
7,911,000
7,976,000
5,953,000
5,774,000
5,535,000
5,614,000
5,911,000
5,863,000
5,930,000
6,131,000
6,358,000
6,510,000
6,469,000
6,469,0006,510,0006,358,0006,131,0005,930,0005,863,0005,911,0005,614,0005,535,0005,774,0005,953,0007,976,0007,911,0008,577,0006,310,0008,209,0007,977,0007,476,0005,978,0007,370,0005,847,0005,712,000
       Other Current Assets 
3,233,000
3,382,000
2,312,000
4,277,000
3,084,000
2,686,000
2,590,000
5,541,000
3,116,000
4,336,000
4,495,000
6,987,000
6,654,000
6,810,000
7,217,000
7,169,000
6,737,000
6,639,000
6,656,000
8,368,000
7,950,000
8,740,000
8,740,0007,950,0008,368,0006,656,0006,639,0006,737,0007,169,0007,217,0006,810,0006,654,0006,987,0004,495,0004,336,0003,116,0005,541,0002,590,0002,686,0003,084,0004,277,0002,312,0003,382,0003,233,000
   > Long-term Assets 
57,003,000
59,667,000
57,189,000
56,914,000
58,739,000
61,272,000
63,223,000
63,824,000
63,938,000
62,023,000
62,436,000
75,428,000
75,484,000
74,979,000
73,520,000
73,438,000
74,394,000
74,492,000
74,773,000
74,507,000
74,404,000
74,425,000
74,425,00074,404,00074,507,00074,773,00074,492,00074,394,00073,438,00073,520,00074,979,00075,484,00075,428,00062,436,00062,023,00063,938,00063,824,00063,223,00061,272,00058,739,00056,914,00057,189,00059,667,00057,003,000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,424,000
21,422,000
21,758,000
22,231,000
22,526,000
23,051,000
23,045,000
23,221,000
23,221,00023,045,00023,051,00022,526,00022,231,00021,758,00021,422,00020,424,00000000000000000
       Goodwill 
18,170,000
19,490,000
19,480,000
19,425,000
19,767,000
20,067,000
20,248,000
20,238,000
20,212,000
18,873,000
18,862,000
21,264,000
21,258,000
21,213,000
21,160,000
21,204,000
21,209,000
21,195,000
21,183,000
21,197,000
21,181,000
21,161,000
21,161,00021,181,00021,197,00021,183,00021,195,00021,209,00021,204,00021,160,00021,213,00021,258,00021,264,00018,862,00018,873,00020,212,00020,238,00020,248,00020,067,00019,767,00019,425,00019,480,00019,490,00018,170,000
       Long Term Investments 
5,621,000
3,779,000
2,111,000
1,469,000
555,000
1,251,000
1,372,000
785,000
544,000
411,000
435,000
370,000
316,000
238,000
984,000
1,015,000
1,290,000
1,214,000
1,306,000
252,000
280,000
357,000
357,000280,000252,0001,306,0001,214,0001,290,0001,015,000984,000238,000316,000370,000435,000411,000544,000785,0001,372,0001,251,000555,0001,469,0002,111,0003,779,0005,621,000
       Intangible Assets 
10,999,000
13,381,000
12,307,000
14,196,000
16,096,000
16,566,000
16,677,000
14,604,000
14,401,000
13,622,000
13,384,000
22,933,000
23,022,000
22,497,000
21,368,000
20,269,000
19,857,000
19,665,000
19,199,000
18,011,000
17,572,000
16,984,000
16,984,00017,572,00018,011,00019,199,00019,665,00019,857,00020,269,00021,368,00022,497,00023,022,00022,933,00013,384,00013,622,00014,401,00014,604,00016,677,00016,566,00016,096,00014,196,00012,307,00013,381,00010,999,000
       Long-term Assets Other 
8,707,000
9,155,000
9,004,000
6,771,000
7,052,000
7,599,000
8,007,000
10,211,000
10,486,000
11,053,000
11,190,000
11,582,000
11,141,000
10,972,000
9,584,000
9,528,000
10,280,000
10,187,000
10,559,000
11,996,000
12,326,000
12,702,000
12,702,00012,326,00011,996,00010,559,00010,187,00010,280,0009,528,0009,584,00010,972,00011,141,00011,582,00011,190,00011,053,00010,486,00010,211,0008,007,0007,599,0007,052,0006,771,0009,004,0009,155,0008,707,000
> Total Liabilities 
54,684,000
56,228,000
56,406,000
58,396,000
58,613,000
62,871,000
60,530,000
66,184,000
63,808,000
57,300,000
57,631,000
67,437,000
65,715,000
63,777,000
62,557,000
63,102,000
60,891,000
65,727,000
65,427,000
69,040,000
65,425,000
68,982,000
68,982,00065,425,00069,040,00065,427,00065,727,00060,891,00063,102,00062,557,00063,777,00065,715,00067,437,00057,631,00057,300,00063,808,00066,184,00060,530,00062,871,00058,613,00058,396,00056,406,00056,228,00054,684,000
   > Total Current Liabilities 
18,543,000
20,085,000
20,684,000
22,220,000
23,483,000
22,178,000
20,405,000
27,327,000
26,361,000
21,906,000
23,728,000
23,872,000
22,316,000
23,168,000
22,998,000
24,239,000
23,131,000
23,394,000
23,094,000
25,694,000
25,099,000
26,060,000
26,060,00025,099,00025,694,00023,094,00023,394,00023,131,00024,239,00022,998,00023,168,00022,316,00023,872,00023,728,00021,906,00026,361,00027,327,00020,405,00022,178,00023,483,00022,220,00020,684,00020,085,00018,543,000
       Short-term Debt 
3,175,000
3,816,000
3,411,000
3,610,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,610,0003,411,0003,816,0003,175,000
       Short Long Term Debt 
3,175,000
3,816,000
3,411,000
3,610,000
6,361,000
4,718,000
2,420,000
6,431,000
7,251,000
2,488,000
3,534,000
2,412,000
1,208,000
2,979,000
1,936,000
1,946,000
2,672,000
2,839,000
887,000
1,372,000
3,077,000
3,071,000
3,071,0003,077,0001,372,000887,0002,839,0002,672,0001,946,0001,936,0002,979,0001,208,0002,412,0003,534,0002,488,0007,251,0006,431,0002,420,0004,718,0006,361,0003,610,0003,411,0003,816,0003,175,000
       Accounts payable 
3,018,000
3,142,000
3,198,000
3,738,000
3,572,000
3,448,000
3,744,000
4,594,000
4,034,000
3,897,000
3,366,000
4,609,000
3,715,000
3,482,000
3,371,000
4,264,000
3,680,000
3,442,000
3,509,000
3,922,000
3,514,000
3,519,000
3,519,0003,514,0003,922,0003,509,0003,442,0003,680,0004,264,0003,371,0003,482,0003,715,0004,609,0003,366,0003,897,0004,034,0004,594,0003,744,0003,448,0003,572,0003,738,0003,198,0003,142,0003,018,000
   > Long-term Liabilities 
36,141,000
36,143,000
35,722,000
36,176,000
35,130,000
40,693,000
40,125,000
38,857,000
37,447,000
35,394,000
33,903,000
43,565,000
43,399,000
40,609,000
39,559,000
38,863,000
37,760,000
42,333,000
42,333,000
43,346,000
40,326,000
42,922,000
42,922,00040,326,00043,346,00042,333,00042,333,00037,760,00038,863,00039,559,00040,609,00043,399,00043,565,00033,903,00035,394,00037,447,00038,857,00040,125,00040,693,00035,130,00036,176,00035,722,00036,143,00036,141,000
       Long term Debt 
22,721,000
22,771,000
22,677,000
22,736,000
21,637,000
26,156,000
26,321,000
25,360,000
24,002,000
24,033,000
22,907,000
30,690,000
30,586,000
28,684,000
28,482,000
28,745,000
28,074,000
34,072,000
33,972,000
33,683,000
31,142,000
34,717,000
34,717,00031,142,00033,683,00033,972,00034,072,00028,074,00028,745,00028,482,00028,684,00030,586,00030,690,00022,907,00024,033,00024,002,00025,360,00026,321,00026,156,00021,637,00022,736,00022,677,00022,771,00022,721,000
       Long-term Liabilities Other 
11,585,000
11,283,000
11,085,000
11,970,000
11,550,000
12,446,000
12,027,000
12,482,000
12,241,000
9,872,000
9,469,000
9,434,000
9,742,000
8,951,000
8,660,000
8,323,000
8,244,000
7,265,000
7,343,000
8,792,000
8,262,000
7,329,000
7,329,0008,262,0008,792,0007,343,0007,265,0008,244,0008,323,0008,660,0008,951,0009,742,0009,434,0009,469,0009,872,00012,241,00012,482,00012,027,00012,446,00011,550,00011,970,00011,085,00011,283,00011,585,000
> Total Stockholder Equity
27,539,000
27,635,000
26,838,000
25,907,000
26,205,000
27,642,000
29,186,000
25,317,000
26,945,000
33,294,000
35,794,000
38,184,000
40,883,000
43,243,000
44,458,000
45,991,000
46,834,000
38,693,000
41,246,000
37,581,000
40,364,000
43,582,000
43,582,00040,364,00037,581,00041,246,00038,693,00046,834,00045,991,00044,458,00043,243,00040,883,00038,184,00035,794,00033,294,00026,945,00025,317,00029,186,00027,642,00026,205,00025,907,00026,838,00027,635,00027,539,000
   Common Stock0000000000000000000000
   Retained Earnings 
44,065,000
45,295,000
45,804,000
46,602,000
48,272,000
49,724,000
51,107,000
47,362,000
48,888,000
48,777,000
51,691,000
53,696,000
56,252,000
58,437,000
59,928,000
61,081,000
62,039,000
54,198,000
57,082,000
53,895,000
56,697,000
60,187,000
60,187,00056,697,00053,895,00057,082,00054,198,00062,039,00061,081,00059,928,00058,437,00056,252,00053,696,00051,691,00048,777,00048,888,00047,362,00051,107,00049,724,00048,272,00046,602,00045,804,00045,295,00044,065,000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 0000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue60,115,000
Cost of Revenue-16,126,000
Gross Profit43,989,00043,989,000
 
Operating Income (+$)
Gross Profit43,989,000
Operating Expense-57,161,000
Operating Income2,954,000-13,172,000
 
Operating Expense (+$)
Research Development30,531,000
Selling General Administrative10,504,000
Selling And Marketing Expenses-
Operating Expense57,161,00041,035,000
 
Net Interest Income (+$)
Interest Income365,000
Interest Expense-1,146,000
Other Finance Cost-0
Net Interest Income-781,000
 
Pretax Income (+$)
Operating Income2,954,000
Net Interest Income-781,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,889,0003,238,000
EBIT - interestExpense = -1,146,000
365,000
1,511,000
Interest Expense1,146,000
Earnings Before Interest and Taxes (EBIT)-3,035,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,889,000
Tax Provision-1,512,000
Net Income From Continuing Ops377,000377,000
Net Income365,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-284,000781,000
 

Technical Analysis of Merck & Co. Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Merck & Co. Inc. The general trend of Merck & Co. Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Merck & Co. Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Merck & Co. Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 101.84 < 102.83 < 105.61.

The bearish price targets are: 98.53 > 96.08 > 95.81.

Tweet this
Merck & Co. Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Merck & Co. Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Merck & Co. Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Merck & Co. Inc.

Merck & Co. Inc Daily Moving Average Convergence/Divergence (MACD) ChartMerck & Co. Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Merck & Co. Inc. The current adx is .

Merck & Co. Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Merck & Co. Inc.

Merck & Co. Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Merck & Co. Inc.

Merck & Co. Inc Daily Relative Strength Index (RSI) ChartMerck & Co. Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Merck & Co. Inc.

Merck & Co. Inc Daily Stochastic Oscillator ChartMerck & Co. Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Merck & Co. Inc.

Merck & Co. Inc Daily Commodity Channel Index (CCI) ChartMerck & Co. Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Merck & Co. Inc.

Merck & Co. Inc Daily Chande Momentum Oscillator (CMO) ChartMerck & Co. Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Merck & Co. Inc.

Merck & Co. Inc Daily Williams %R ChartMerck & Co. Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Merck & Co. Inc.

Merck & Co. Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Merck & Co. Inc.

Merck & Co. Inc Daily Average True Range (ATR) ChartMerck & Co. Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Merck & Co. Inc.

Merck & Co. Inc Daily On-Balance Volume (OBV) ChartMerck & Co. Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Merck & Co. Inc.

Merck & Co. Inc Daily Money Flow Index (MFI) ChartMerck & Co. Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Merck & Co. Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Merck & Co. Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Merck & Co. Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose100.200
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Merck & Co. Inc with someone you think should read this too:
  • Are you bullish or bearish on Merck & Co. Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Merck & Co. Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Merck & Co. Inc

I send you an email if I find something interesting about Merck & Co. Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Merck & Co. Inc.

Receive notifications about Merck & Co. Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.